Theranos Faces Two Potential Class Action Suits
This article was originally published in The Gray Sheet
Two consumers have filed attempted class action suits against Theranos that claim the lab-testing company's advertising misled consumers as to the safety and reliability of its products. The company denies the allegations. Theranos is facing exclusion from CMS over repeated lab problems.
You may also be interested in...
In another blow from the US government, securities regulators have severely penalized Theranos and its cofounder, Elizabeth Holmes, for allegedly lying to investors to raise funds.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.